My Profile e-Learning Center my.ASTHO Contact Us

Filter Results

Clear All Filters

Topic

Product Type

Location

Contributor

Published Date

Displaying 5 results for

GO
Search Filters: Guam cancel Vermont cancel

Domestic Holiday Travel Pandemic Restrictions and Recommendations

Health Policy Update,
COVID and Community Mitigation,
COVID and Law/Policy,
COVID Preparedness,
Tribal Health,
Emergency Powers,
State Health Policy,
Territories and Freely Associated States,
Alabama,
Alaska,
American Samoa,
Arizona,
Arkansas,
California,
Colorado,
Connecticut,
Delaware,
Washington, D.C.,
Federated States of Micronesia,
Florida,
Georgia,
Guam,
Hawaii,
Idaho,
Illinois,
Indiana,
Iowa,
Kansas,
Kentucky,
Louisiana,
Maine,
Marshall Islands,
Maryland,
Massachusetts,
Michigan,
Minnesota,
Mississippi,
Missouri,
Montana,
Nebraska,
Nevada,
New Hampshire,
New Jersey,
New Mexico,
New York,
North Carolina,
North Dakota,
Northern Mariana Islands,
Ohio,
Oklahoma,
Oregon,
Palau,
Pennsylvania,
Puerto Rico,
Rhode Island,
South Carolina,
South Dakota,
Tennessee,
Texas,
Utah,
Vermont,
Virgin Islands,
Virginia,
West Virginia,
Wisconsin,
Wyoming,
Maggie Davis

The 2020 holiday season is coinciding with a nationwide surge of COVID-19 cases. With great concern that holiday travel to see loved ones may exacerbate community spread of the virus, many states are ...

2023 Legislative Session Update: Part One

Health Policy Update,
State Health Policy,
Territorial Health Policy,
Mental Health,
HIV,
Opioids,
Tobacco Control,
PFAS,
Florida,
Guam,
Hawaii,
Illinois,
Indiana,
Kentucky,
Mississippi,
New Mexico,
New York,
Oklahoma,
South Dakota,
Utah,
Vermont,
Virginia,
West Virginia,
Beth Giambrone,
Christina Severin,
Parker Beene,
Maggie Davis

A mid-session legislative update on five of ASTHO's top 10 public health state policy issues to watch in 2023: tobacco, HIV, mental health, PFAS, and opioids.

Updated Rundown of State and Territorial COVID-19 Mask Requirements

Health Policy Update,
COVID and Community Mitigation,
COVID and Law/Policy,
State Health Policy,
Territorial Health Policy,
Federal Government Affairs,
Public Health Law,
Pandemics,
Women, Infant, and Family Health,
Alabama,
Arkansas,
California,
Colorado,
Connecticut,
Delaware,
Washington, D.C.,
Guam,
Hawaii,
Illinois,
Indiana,
Kansas,
Kentucky,
Louisiana,
Maine,
Maryland,
Massachusetts,
Michigan,
Minnesota,
Mississippi,
Montana,
Nevada,
New Hampshire,
New Jersey,
New Mexico,
New York,
North Carolina,
Ohio,
Oregon,
Pennsylvania,
Puerto Rico,
Rhode Island,
Texas,
Vermont,
Virgin Islands,
Virginia,
West Virginia,
Wisconsin,
Andy Baker-White

Several states and territories, as well as many local governments, are going beyond recommendations and requiring individuals to wear face coverings when they are in public settings and spaces (i.e. ...

Health Equity Policy Toolkit

Toolkit,
Social Determinants of Health,
State Health Policy,
Federal Government Affairs,
Territorial Health Policy,
Public Health Law,
Elimination of Disparities,
Race and Public Health,
Tribal Health,
American Samoa,
Colorado,
Connecticut,
Delaware,
Federated States of Micronesia,
Guam,
Illinois,
Marshall Islands,
Maryland,
Massachusetts,
Michigan,
Montana,
Nebraska,
Nevada,
North Dakota,
Northern Mariana Islands,
Palau,
Puerto Rico,
Texas,
Vermont,
Virgin Islands,
Washington, D.C.,
Kimberlee Wyche Etheridge,
ASTHO Communications

This toolkit is designed to support public health leaders in leveraging the policy development process to achieve health equity in their jurisdiction.

How the Emergence of Xylazine Impacts Overdose Prevention Policy

State Health Policy,
Overdose Prevention,
Alaska,
Colorado,
Guam,
Maine,
Maryland,
Nebraska,
New York,
Northern Mariana Islands,
Pennsylvania,
South Carolina,
Vermont,
Illinois,
New Hampshire,
Delaware,
New Jersey,
Florida,
Massachusetts,
Utah,
Michigan,
Rhode Island,
Oklahoma,
West Virginia,
Indiana,
Puerto Rico,
JoAnne McClure,
Victoria Pless,
Health Policy Update,
Ohio

How the Emergence of Xylazine Impacts Overdose Prevention Policy overdose prevention policy, overdose crisis, fatal overdoses, emergence of xylazine, illicit drug supply, toxicological testing, ...